Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05592483 |
|---|---|
| Brief Title: | An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer (DB RESPOND) |
| First Submitted : | October 20, 2022 |
| First Submitted that Met QC Criteria : | October 20, 2022 |
| First Posted : | October 24, 2022 |
| Last Update Submitted that Met QC Criteria : | April 17, 2024 |
| Last Update Posted : | April 18, 2024 |